Pharmafile Logo
Pharmafocus logo
Advanced Search

Shire

Showing 15 posts of 170 posts found.

angus_russell_questcor

Questcor hires Shire’s chief executive

June 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Questcor, Shire

Biopharma firm Questcor Pharmaceuticals has appointed the recently-retired chief executive of Shire to its Board of directors.   Angus Russell …

Appointment

BMS hires Ann Powell Judge from Shire

February 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann Powell Judge, BMS, Shire

BMS has announced that Ann Powell Judge will join the company as senior vice president, Human Resources.From March Judge will …

Appointment
Shire image

Shire ADHD drug for UK

February 14, 2013
Sales and Marketing ADHD, Shire, Vyvanse, elvanse

Shire’s attention-deficit hyperactivity disorder (ADHD) drug Elvanse has been given the go-ahead for use in the UK. Elvanse (lisdexamfetamine dimesylate), …

News
Shire image

Shire pays Impax $48 million

February 12, 2013
Sales and Marketing ADHD, Adderall, Impax, Shire

Shire has paid $48 million to settle a long-running legal spat with Impax Laboratories over Shire’s supply of an authorised …

News
jonas_jeffery_5x7_300dpi_srgb

Jeff Jonas joins Shire’s Leadership Team

November 15, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeff Jonas, Shire

Shire has announced that Jeff Jonas has been appointed president of Shire’s Regenerative Medicine (RM) business and will join the …

Appointment
Shire image

Shire poaches new head from Bayer

October 26, 2012
Sales and Marketing Angus Russell, Flemming Omskov, Shire

Flemming Ornskov, currently chief marketing officer at Bayer, is to take over at Dublin-based Shire Pharmaceuticals next year. He will …

News
steven_gillis

Steven Gillis to join Shire Board of directors

September 19, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Steven Gillis

Shire has announced that Dr Steven Gillis will join the Board of directors in October this year. On joining the …

Appointment
Shire image

Shire posts strong quarter results

August 2, 2012
Sales and Marketing ADHD, Adderall XR, Pfizer, Q2, Shire, results

Shire has posted a set of healthy financials for the second quarter, buoyed by its ADHD and rare drug portfolio. …

News
Shire image

Generic approval for Shire’s hyperactivity drug

June 26, 2012
Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …

News
Pfizer image

Pfizer Gaucher drug rejected by CHMP

June 25, 2012
Sales and Marketing Elelyso, FDA, Gaucher, Pfizer, Shire, Vpriv

A European committee has refused marketing authorisation for Pfizer’s Gaucher disease drug Elelyso, as a competitor drug has exclusivity to …

News
Social media

ABPI: we don’t have the answers for digital yet

June 14, 2012
Medical Communications, Sales and Marketing ABPI, Bayer, Deepak Khanna, Shire, digital, online

Pharma’s use of digital media is posing questions that can’t yet be answered, says the new ABPI president Deepak Khanna. …

News
ann_judge_2

Shire makes two senior appointments

June 6, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Colpman, Judge, Shire

Shire has announced the promotion of David Colpman and Ann Judge (pictured) as two senior leaders within the firm.  Colpman, …

Appointment

ABPI to help pharma with digital communications

May 4, 2012
Medical Communications ABPI, Code breach, PMCPA, Shire, digital, pharma

The ABPI has set up a new group to help pharma with its online communications.  The UK industry body said …

News

Pfizer enters Gaucher disease market

May 3, 2012
Sales and Marketing Cerezyme, Elelyso, Gaucher, Genzyme, Pfizer, Shire, Vpriv

Pfizer has gained FDA approval for its new Gaucher disease drug Elelyso.  Elelyso (taliglucerase alfa) is an enzyme replacement therapy …

News
Shire's Vpriv website

Shire’s Vpriv website in breach of ABPI Code

April 24, 2012
Medical Communications, Sales and Marketing ABPI, Genzyme, PMCPA, Shire, Vpriv, code

Shire’s website for its Gaucher’s disease drug Vpriv has fallen foul of the ABPI’s Code of Conduct.  The complaint was …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026